Article

Relapse prediction in multiple myeloma patients treated with isatuximab, carfilzomib, and dexamethasone

2024-05-03

Abstract excerpt

Multiple myeloma (MM) patients experience repeated cycles of treatment response and relapse, yet despite close monitoring of disease status through M protein measurements, no standard model exists for relapse prediction in MM. We investigate the feasibility of predicting relapse using a hierarchical Bayesian model of subpopulation dynamics by training and testing the model on 229 patients from the IKEMA trial. Aft...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 80dc766c-928b-5147-96bb-14ef65c6f2d8
DOI: 10.1101/2024.05.02.24306607

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Relapse prediction in multiple myeloma patients treated with isatuximab, carfilzomib, and dexamethasoneDOI 10.1101/2024.05.02.24306607Read

Dynamic multimodal survival prediction in multiple myeloma integrating gene expression, longitudinal laboratories, and treatment historySemantic proximity Read

Myeloma Cell Dynamics in Response to Treatment Supports a Model of Hierarchical Differentiation and Clonal EvolutionSemantic proximity Read

A computational model of MGUS progression to Multiple Myeloma identifies optimum screening strategies and their effects on mortalitySemantic proximity Read

Functional high-risk phenotype predicts poor survival in multiple myeloma independent of front-line treatment: A secondary analysis of CIBMTR data.Semantic proximity Read

Machine Learning Models for Predicting Multiple Myeloma Staging and MGUS Progression Using Gene Expression DataSemantic proximity Read

Establishing Measurable Residual Disease Trajectories for Patients on Treatment for Newly Diagnosed Multiple Myeloma as Benchmark for Deployment of T-cell Redirection TherapySemantic proximity Read

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patientsSemantic proximity Read

Identification of Pathogenesis and Prognoses of Relapse in Myeloma by Bioinformatic MethodSemantic proximity Read

Analysis of long‐term survival in multiple myeloma after first‐line autologous stem cell transplantation: impact of clinical risk factors and sustained responseSemantic proximity Read

Real-World Treatment Patterns and Clinical Outcomes in Patients With Multiple Myeloma Previously Treated With Lenalidomide and an Anti-CD38 Monoclonal AntibodySemantic proximity Read

Pattern of Use and Efficacy of Daratumumab-based Therapy in Patients With Multiple Myeloma in a Real-world Setting: a Single Institution ExperienceSemantic proximity Read

Potential role of daratumumab in the treatment of multiple myelomaSemantic proximity Read